{"metadata": {"source": "pubchem", "title": "Ketamine | C13H16ClNO | CID 3821 - PubChem", "description": "Ketamine | C13H16ClNO | CID 3821 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3821", "drug": "Ketamine", "cid": 3821, "char_count": 145335, "word_count": 19110, "doc_id": "doc_44", "num_chunks": 204, "chunk_id": "44::chunk_48", "document_index": 44, "latency_s": 1.3506034000020009, "prompt_toks": 38244, "completion_toks": 80, "relevance_score": 3.138147e-06}, "content": "Drug: Ketamine | cid: 3821\nSource: pubchem | Source description: Ketamine | C13H16ClNO | CID 3821 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    NIH; DailyMed. Current Medication Information for Ketamine hydrochloride- ketamine hydrochloride injection (Updated: May 2017). Available from, as of August 23, 2017: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=58487c78-a641-4278-acc0-343596ee8683\n\nThe pharmacokinetics of ketamine-HCl in the cat was described by a 2-compartment open model. The n-dealkylated amine metabolite of ketamine-HCl was detected in plasma of all cats and peak levels which were 0.27 to 0.38 times ketamine-HCl level were reached between 5 and 20 min after injection.\n\nHeavner JE, Bloedow DC; Vet Anesth 6 (2): 16 (1979)\n\n\n                    Context: \n                    This excerpt details the pharmacokinetics of ketamine-HCl in cats, modeled by a 2-compartment open system, highlighting detection of a key n-dealkylated metabolite with peak levels reached between 5 and 20 minutes post-injection. It provides specific metabolic data relevant to veterinary studies, complementing the broader pharmacological and metabolic profiles of ketamine presented in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Gabapentin | C9H17NO2 | CID 3446 - PubChem", "description": "Gabapentin | C9H17NO2 | CID 3446 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3446", "drug": "Gabapentin", "cid": 3446, "char_count": 132543, "word_count": 16838, "doc_id": "doc_28", "num_chunks": 178, "chunk_id": "28::chunk_46", "document_index": 28, "latency_s": 1.4319101000000956, "prompt_toks": 35469, "completion_toks": 68, "relevance_score": 5.8505316e-07}, "content": "Drug: Gabapentin | cid: 3446\nSource: pubchem | Source description: Gabapentin | C9H17NO2 | CID 3446 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    In cats ... elimination half life of 2.8 hours is similar to dogs.\n\nPlumb D.C. Veterinary Drug Handbook. 8th ed. (pocket). Ames, IA: Wiley-Blackwell, 2015., p. 649\n\n8.8 Mechanism of Action\n\n\n                    Context: \n                    This chunk provides specific pharmacokinetic data on gabapentin's elimination half-life in cats, highlighting its similarity to dogs, which is relevant for veterinary considerations. It is situated within the detailed pharmacokinetics and mechanism of action sections of the comprehensive document, emphasizing species-specific data that support understanding gabapentin's absorption and excretion properties.\n                "}
{"metadata": {"source": "pubchem", "title": "Methadone | C21H27NO | CID 4095 - PubChem", "description": "Methadone | C21H27NO | CID 4095 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4095", "drug": "Methadone", "cid": 4095, "char_count": 207830, "word_count": 28065, "doc_id": "doc_48", "num_chunks": 289, "chunk_id": "48::chunk_66", "document_index": 48, "latency_s": 1.5281691999989562, "prompt_toks": 53826, "completion_toks": 91, "relevance_score": 5.7598277e-07}, "content": "Drug: Methadone | cid: 4095\nSource: pubchem | Source description: Methadone | C21H27NO | CID 4095 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Plumb D.C. Veterinary Drug Handbook. 8th ed. (pocket). Ames, IA: Wiley-Blackwell, 2015., p. 936\n\nIn cats, after administration of methadone IV (0.3 mg/kg) or via oral transmucosal (OTM) administration (0.6 mg/kg), peak levels occurred at 10 minutes (IV) and 2 hours (OTM).\n\nPlumb D.C. Veterinary Drug Handbook. 8th ed. (pocket). Ames, IA: Wiley-Blackwell, 2015., p. 936\n\n\n                    Context: \n                    This excerpt provides pharmacokinetic data on methadone administration in cats, reporting peak blood levels after IV (0.3 mg/kg) and oral transmucosal (OTM) (0.6 mg/kg) dosing, with peak levels at 10 minutes and 2 hours respectively. As part of the comprehensive physical and pharmacokinetic profile in the full document, it highlights species-specific absorption characteristics relevant for veterinary use and overdose assessment.\n                "}
